pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-5p | |||||||||||||||||||||||||||
Sequence | 23| AUGCUGACAUAUUUACUAGAGG |44 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CTPS2 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | CTP synthase 2 | ||||||||||||||||||||
Transcript | NM_001144002 | ||||||||||||||||||||
Other Transcripts | NM_019857 , NM_175859 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CTPS2 | |||||||||||||||||||||
3'UTR of CTPS2 (miRNA target sites are highlighted) |
>CTPS2|NM_001144002|3'UTR 1 AATGAATACATGACTGGGAATAATGGGGACTGCCTGTGAGGCCTCTGAAATAATTGAAGGCAAGATGAAGGAACTATCTG 81 AAGAAATCACTACACTCTTAGAGAATCCCTCTGTTCTCCAGCAAACATGGGATGTAAAGCCTCACAGGGAATCTGATAAT 161 ACATACTTCTGTCAACCAGAACCAGAGGGGTAGTTTTCTTTTCCCTCCAGAGGCAGCCTTTGGTACTTAAAATATCTGTA 241 GCTGATTAAATTTTTCCCAACAACCTCACTGGGGAGAAAGTGTGTTCATGTTTTGTCCAGCGGATCAGGATGTTAGGATG 321 ACGAGCAAGAGTCCAGGTCACTGTGCCTTTGCTGTGTTGTATGGAAAGGATGGCAGGGAACATGCTGTAAGTAATTTTGA 401 GTAAGAAAATGAGTCACTGTGTTACCTGGAACTCAGCCACAGATTTGTGTGTGGTCCAAGATCATTGCAGTTTCTCACCC 481 TGTTTATTTCCTGGTAAAAGTAAAATTGAATAGGTCCAAGACTTGGGGGTGGCAAGTAAGGCTTTGCCTCAGGCACAAAA 561 TTTAAGGGGGCTCCAAAAAACTCAGGAATCAAGATCAGCAATACAGTCTGAGTATCCCTTATGTGAAATGCTTGGGGCTA 641 GAAGTGTTTTGAATTTCAGATTTTGGAATATTTGCATATACATGCGATATCTTGGGGATGAGACTCAAGACTAAACATGA 721 AATTCATTTATGCTTCATATACACCTTATATACATAGCCTAAAGGTAATTTGATACAATATTTTAAATAATTTTGTGCAT 801 GAAACAAAGTTTCGACTGCATTTTGACTGTGATTTCTGGCATGAGATCAGTTATGGAATTTTCCACTTCTAGCGTCATGT 881 TGGCATTCAGAAATTTTGAAATTTTGGAGCATTTTGGATTTTCAGATTAGGGATGCTCAACCTGTATATATATTTTTTAA 961 TCGACGTGAAATTCACGTAACATAGAATTAACCATTTTGAAGTGAACAATTTGGTTGCATTCACTGATGTTGAGCAACCA 1041 CCACCTTTAACTATTTCCAAAACATTTTCATCACTCCAAAATAAATGCCTGTACACACTAGCAGTCACTCCCTATCTTCC 1121 CCTCCACCTGTCCGCTGGCAACCACTGATCTCCTTTTTATTTCTGTGGCTTTTTCTATTCTGGATATTTCATATAAGTGG 1201 AATTACACAATATATGTGGTCTTTTGTGTCTGGCTTCTTCTGAGACAGTAGGAAGGGGGCTTGGCTTTGGCTCACCCCCA 1281 CTAGAGCATTTTTTCATGCATTCCCACTGATCACAAAACCCATACTACTACCTCATTGACACCATACCTGCTAACCTCGA 1361 GGCTTTAGTCATACAAAGAAAATGGCCTTTCTGTATTGTTCTTCTGTGCTCTCATAATGCTTAACCATGTCTTTTACTTA 1441 AACAATTCCAGGAACTGGCCTTAGGAGATCCAAATAGGGAACCAAGATTGCAGAGTGTCCCATCTTGGGAGGGAATGCTG 1521 AATAATTAATTGATTTACAGCCTTGTTGCCGCTGGCCAGACCACCAGGTGGCCCATTACTCGAGATGATCATCACAACCA 1601 GATGATGCTAACCTATATCCTCTACCCTTCGCGTGCTTTGTCTGGGAAGTCTTTTGGCCCCATGTCAGTTTCTATTGCAT 1681 TGAGAGCCCAAGAGCCCCTGGTCAGTCAGGCTTCCATTTAGCATGGCGTTTGCAAGGTTTACCCATGTTGTAGCATGTGT 1761 CAGAATTTCATTCCTTTCTATGGCTGAATAAAATTCCATTGTATGAATATACCACAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000443824.1 | 3UTR | AUACAGUCUGAGUAUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
44 hsa-miR-628-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT037783 | NELFE | negative elongation factor complex member E | 1 | 1 | ||||||||
MIRT200944 | ZNF264 | zinc finger protein 264 | 2 | 6 | ||||||||
MIRT441916 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT443436 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT443447 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT443906 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT449750 | SMYD2 | SET and MYND domain containing 2 | 2 | 2 | ||||||||
MIRT461377 | SLFN12L | schlafen family member 12 like | 2 | 2 | ||||||||
MIRT466416 | TFAP2A | transcription factor AP-2 alpha | 2 | 8 | ||||||||
MIRT486594 | CTPS2 | CTP synthase 2 | 2 | 2 | ||||||||
MIRT491945 | VPS52 | VPS52, GARP complex subunit | 2 | 2 | ||||||||
MIRT513492 | SSR1 | signal sequence receptor subunit 1 | 2 | 6 | ||||||||
MIRT528599 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT531325 | SEMA3D | semaphorin 3D | 2 | 2 | ||||||||
MIRT532082 | RTTN | rotatin | 2 | 2 | ||||||||
MIRT532563 | CSTF1 | cleavage stimulation factor subunit 1 | 2 | 2 | ||||||||
MIRT532976 | ZNF12 | zinc finger protein 12 | 2 | 2 | ||||||||
MIRT534075 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 2 | ||||||||
MIRT536103 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT536183 | MAOB | monoamine oxidase B | 2 | 2 | ||||||||
MIRT543755 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT550000 | KIAA0408 | KIAA0408 | 2 | 2 | ||||||||
MIRT551237 | COLEC10 | collectin subfamily member 10 | 2 | 2 | ||||||||
MIRT567554 | FEN1 | flap structure-specific endonuclease 1 | 2 | 2 | ||||||||
MIRT570387 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | 2 | 2 | ||||||||
MIRT570808 | LYN | LYN proto-oncogene, Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT576346 | Pxdn | peroxidasin | 2 | 2 | ||||||||
MIRT576520 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT576893 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT606796 | BICD2 | BICD cargo adaptor 2 | 2 | 2 | ||||||||
MIRT625909 | GBP6 | guanylate binding protein family member 6 | 2 | 2 | ||||||||
MIRT626869 | PDGFRA | platelet derived growth factor receptor alpha | 2 | 2 | ||||||||
MIRT643603 | IRAK4 | interleukin 1 receptor associated kinase 4 | 2 | 2 | ||||||||
MIRT645451 | FOXE1 | forkhead box E1 | 2 | 2 | ||||||||
MIRT652265 | TOMM20 | translocase of outer mitochondrial membrane 20 | 2 | 2 | ||||||||
MIRT689023 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT691057 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT704712 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT713069 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT719483 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT732944 | AGAP2-AS1 | AGAP2 antisense RNA 1 | 3 | 0 | ||||||||
MIRT732945 | KLF12 | Kruppel like factor 12 | 3 | 0 | ||||||||
MIRT733520 | BMP2 | bone morphogenetic protein 2 | 3 | 0 | ||||||||
MIRT733521 | ETV1 | ETS variant 1 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|